4//SEC Filing
Azamian Bobak R. 4
Accession 0001819790-25-000022
CIK 0001819790other
Filed
Mar 6, 7:00 PM ET
Accepted
Mar 7, 4:17 PM ET
Size
7.8 KB
Accession
0001819790-25-000022
Insider Transaction Report
Form 4
Azamian Bobak R.
DirectorPresident/CEO and Board Chair
Transactions
- Award
Restricted Stock Units
2025-03-05+59,512→ 59,512 total→ Common Stock (59,512 underlying) - Award
Stock Option (right to buy)
2025-03-05+90,736→ 90,736 totalExercise: $44.54Exp: 2035-03-04→ Common Stock (90,736 underlying)
Footnotes (3)
- [F1]25% of the option shares shall vest on March 5, 2026, and 1/48th of the option shares shall vest each month thereafter for a period of 3 years, subject to the Reporting Person's continuous service.
- [F2]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.
- [F3]The RSUs will vest in four equal annual installments on March 15th of each of 2026, 2027, 2028, and 2029, subject to the Reporting Person's continuous service.
Documents
Issuer
Tarsus Pharmaceuticals, Inc.
CIK 0001819790
Entity typeother
Related Parties
1- filerCIK 0001827672
Filing Metadata
- Form type
- 4
- Filed
- Mar 6, 7:00 PM ET
- Accepted
- Mar 7, 4:17 PM ET
- Size
- 7.8 KB